Founded in 2019 and based in Montreal, MY01 envisions a world where every disease is quantifiable, enabling precise, personalized care for all patients. Specializing in managing limb ischemia and compartment syndrome, our tools provide proactive monitoring and actionable insights through a connected care team that benefits patients, providers, and payers. MY01 is commercial in the USA, Europe, and Canada, setting new standards in healthcare.